A comprehensive review of flue gas bio-mitigation: chemolithotrophic interactions with flue gas in bio-reactors as a sustainable possibility for technological advancements.

Flue gas mitigation technologies aim to reduce the environmental impact of flue gas emissions, particularly from industrial processes and power plants. One approach to mitigate flue gas emissions involves bio-mitigation, which utilizes microorganisms to convert harmful gases into less harmful or inert substances. The review thus explores the bio-mitigation efficiency of chemolithotrophic interactions with flue gas and their potential application in bio-reactors. Chemolithotrophs are microorganisms that can derive energy from inorganic compounds, such as carbon dioxide (CO2), nitrogen oxides (NOx), and sulfur dioxide (SO2), present in the flue gas. These microorganisms utilize specialized enzymatic pathways to oxidize these compounds and produce energy. By harnessing the metabolic capabilities of chemolithotrophs, flue gas emissions can be transformed into value-added products. Bio-reactors provide controlled environments for the growth and activity of chemolithotrophic microorganisms. Depending on the specific application, these can be designed as suspended or immobilized reactor systems. The choice of bio-reactor configuration depends on process efficiency, scalability, and ease of operation. Factors influencing the bio-mitigation efficiency of chemolithotrophic interactions include the concentration and composition of the flue gas, operating conditions (such as temperature, pH, and nutrient availability), and reactor design. Chemolithotrophic interactions with flue gas in bio-reactors offer a potentially efficient approach to mitigating flue gas emissions. Continued research and development in this field are necessary to optimize reactor design, microbial consortia, and operating conditions. Advances in understanding the metabolism and physiology of chemolithotrophic microorganisms will contribute to developing robust and scalable bio-mitigation technologies for flue gas emissions.

Reforming CO2 bio-mitigation utilizing Bacillus cereus from hypersaline realms in pilot-scale bubble column bioreactor.

The bubble column reactor of 10 and 20 L capacity was designed to bio-mitigate 10% CO2 (g) with 90% air utilizing thermophilic bacteria (Bacillus cereus SSLMC2). The maximum biomass yield during the growth phase was obtained as 9.14 and 10.78 g L-1 for 10 and 20 L capacity, respectively. The maximum removal efficiency for CO2 (g) was obtained as 56% and 85% for the 10 and 20 L reactors, respectively. The FT-IR and GC-MS examination of the extracellular and intracellular samples identified value-added products such as carboxylic acid, fatty alcohols, and hydrocarbons produced during the process. The total carbon balance for CO2 utilization in different forms confirmed that B. cereus SSLMC2 utilized 1646.54 g C in 10 L and 1587 g of C in 20 L reactor out of 1696.13 g of total carbon feed. The techno-economic assessment established that the capital investment required was $286.21 and $289.08 per reactor run of 11 days and $0.167 and $0.187 per gram of carbon treated for 10 and 20 L reactors, respectively. The possible mechanism pathways for bio-mitigating CO2 (g) by B. cereus SSLMC2 were also presented utilizing the energy reactions. Hence, the work presents the novelty of utilizing thermophilic bacteria and a bubble column bioreactor for CO2 (g) bio-mitigation.

Sustainable valorization of macroalgae residual biomass, optimization of pyrolysis parameters and life cycle assessment.

The major challenges for the current climate change issue are an increase in global energy demand, a limited supply of fossil fuels, and increasing carbon footprints from fossil fuels, which have necessitated the exploration of sustainable alternatives to fossil fuels. Biorefineries offer a promising path to sustainable fuel production, converting biomass into biofuels using diverse technologies. Aquatic biomass, such as macroalgae in this context, represents an abundant and renewable biomass resource that can be cultivated from water bodies without competing with traditional agricultural land. Despite this, the potential of macroalgae for biofuel production remains largely untapped, with very limited studies addressing their viability and efficiency. This study investigates the efficient conversion of unexplored macroalgae biomass through a biorefinery process that involves lipid extraction to produce biodiesel, along with the production of biochar and bio-oil from the pyrolysis of residual biomass. To improve the effectiveness and overall performance of the pyrolysis system, Response Surface Methodology (RSM) was utilized through a Box-Behnken design to systematically investigate how alterations in temperature, reaction time, and catalyst concentration influence the production of bio-oil and biochar to maximize their yields. The results showed the highest bio-oil yield achieved to be 36 %, while the highest biochar yield reached 45 %. The integration of Life Cycle Assessment (LCA) in the study helps to assess carbon emission and environmental burdens and identify potential areas for optimization, such as resource efficiency, waste management, and energy utilization. The LCA results contribute to the identification of potential environmental hotspots and guide the development of strategies to optimize the overall sustainability of the biofuel production process. The LCA results indicate that the solvent (chloroform) used in transesterification contributes significantly to greenhouse gas emissions and climate change impacts. Therefore, it is crucial to explore alternative, safe solvents that can mitigate the environmental impacts of transesterification.

Energetic assessment of fixation of CO2 and subsequent biofuel production using B. cereus SM1 isolated from sewage treatment plant.

The ongoing work on global warming resulting from green house gases (GHGs) has led to explore the possibility of bacterial strains which can fix carbon dioxide (CO2) and can generate value-added products. The present work is an effort in this direction and has carried out an exhaustive batch experiments for the fixation of CO2 using B. Cereus SM1 isolated from sewage treatment plant (STP). The work has incorporated 5-day batch run for gaseous phase inlet CO2 concentration of 13 ± 1 % (%v/v). 84.6 (±5.76) % of CO2 removal was obtained in the gaseous phase at mentioned CO2 concentration (%v/v). Energetic requirement for CO2 fixation was assessed by varying Fe[II] ion concentration (0-200 ppm) on the per-day basis. The cell lysate obtained from CO2 fixation studies (Fe[II] ion = 100 ppm) was analyzed using Fourier transformation infrared spectroscopy (FTIR) and gas chromatography-mass spectroscopy (GC-MS). This analysis confirmed the presence of fatty acids and hydrocarbon as valuable products. The hydrocarbons were found in the range of C11-C22 which is equivalent to light oil. The obtained fatty acids were found in the range of C11-C19. The possibility of fatty acid conversion to biodiesel was explored by carrying out the transesterification reaction. The yield of biodiesel was obtained as 86.5 (±0.048) % under the transesterification reaction conditions. Results of this research work can provide the valuable information in the implementation of biomitigation of CO2 at real scenario.

Bioadhesive floating microsponges of cinnarizine as novel gastroretentive delivery: Capmul GMO bioadhesive coating versus acconon MC 8-2 EP/NF with intrinsic bioadhesive property.

INTRODUCTION: The study was aimed at the development of low-density gastroretentive bioadhesive microsponges of cinnarizine by two-pronged approach (i) coating with bioadhesive material and (ii) exploration of acconon MC 8-2 EP/NF as bioadhesive raw material for fabrication. MATERIALS AND METHODS: Microsponges were prepared by quasi-emulsion solvent diffusion method using 32 factorial design. Capmul GMO was employed for bioadhesive coating. In parallel, potential of acconon for the fabrication of bioadhesive floating microsponges (A8) was assessed. RESULTS: Formulation with entrapment efficiency = 82.4 ± 3.4%, buoyancy = 82.3 ± 2.5%, and correlation of drug release (CDR8h) = 88.7% ± 2.9% was selected as optimized formulation (F8) and subjected to bioadhesive coating (BF8). The %CDR8h for A8 was similar to BF8 (87.2% ± 3.5%). Dynamic in vitro bioadhesion test revealed comparable bioadhesivity with BF8. The ex vivo permeation across gastric mucin displayed 63.16% for BF8 against 56.74% from A8; affirmed the bioadhesivity of both approaches. CONCLUSION: The study concluded with the development of novel bioadhesive floating microsponges of cinnarizine employing capmul GMO as bioadhesive coating material and confirmed the viability of acconon MC 8-2EP/NF as bioadhesive raw material for sustained targeted delivery of drug.

A comprehensive study on the behavior of a novel bacterial strain Acinetobacter guillouiae for bioremediation of divalent copper.

Biological methods have been successfully used to mitigate heavy metal pollution problem in wastewater. The present study was aimed towards isolation of a novel indigenous bacterial strain, Acinetobacter guillouiae from activated sludge and its subsequent application in remediation of copper (Cu(2+)) from aqueous solution. Kinetic study of bioremediation was performed for initial Cu(2+) concentrations ranging from 40 to 150 mg L(-1). Optimum values of nutrient dosage, pH, macronutrients [Nitrogen (N)-Phosphorus (P)-Potassium (K)] dosage, aerobic and facultative anaerobic conditions, temperature, and inoculum volume were determined by conducting separate batch bioremediation studies at 80 mg L(-1) initial concentration of Cu(2+). Kinetic study showed that A. guillouiae removed 98.7 % Cu(2+) for 80 mg L(-1) initial concentration of Cu(2+) after 16 h at an optimum solution pH of 7.0. Results also revealed that A. guillouiae showed maximum growth at double the standard composition of N, P and standard composition of K in nutrient dosage. Experimental data obtained in present study were utilized to validate different growth kinetic models such as Monod, Powell, Haldane, Luong, and Edwards. Growth kinetics of A. guillouiae was better understood by Luong model (R (2) = 0.97). Higher values of coefficient of determination (R (2) = 0.97-0.99) confirmed the suitability of the three-half-order kinetic model for representing the Cu(2+) bioremediation. A. guillouiae showed a robust removal mechanism for the bioremediation of Cu(2+).

Oral bioavailability: issues and solutions via nanoformulations.

The delivery of drugs through the oral route is regarded as most optimal to achieve desired therapeutic effects and patient compliance. However, poor pharmacokinetic profiles of oral drug candidates remains an area of concern, and approaches to enhance their bioavailability are widely cited in the literature. Traditionally, the approaches have been confined to molecular optimization of the drug molecule, which has gradually evolved into development of microsized and nanosized formulations. Nanoformulations, by virtue of their nanosize, are widely acclaimed for circumventing the obstacles of poor pharmacokinetics. In this review, an attempt has been made to discuss existing challenges of bioavailability and approaches to overcome the same, with in-depth compilation of the literature on nanoformulations. The nanoformulations reviewed include nanocrystals, nanoemulsions, polymeric nanoparticles, self-nanoemulsifying drug delivery systems, dendrimers, carbon nanotubes, polymeric micelles and lipid nanocarriers. This review confirms the potential of nanomedicines to improve the pharmacokinetics of drugs via nanoformulations. Chemotherapeutic applications and patent reports are also compiled in the review. Despite the promising benefits, nanomedicines are associated with hazards to human health. Hence, the review also deals with toxicological consequences of nanomedicines, and with in vitro/in vivo screening methods to assess bioavailability as per regulatory considerations. Nanotechnology has been shown to facilitate the clinical translation of drug candidates that were deemed to be bioavailability failures. Conclusively, nanotechnological approaches to particle design and formulation are beginning to expand the market for many drugs with improved bioavailability and therapeutics. However, dedicated efforts are needed to develop advanced nanomedicines with minimal or no adverse effects.

Recent advances in delivery systems and therapeutics of cinnarizine: a poorly water soluble drug with absorption window in stomach.

Low solubility causing low dissolution in gastrointestinal tract is the major problem for drugs meant for systemic action after oral administration, like cinnarizine. Pharmaceutical products of cinnarizine are commercialized globally as immediate release preparations presenting low absorption with low and erratic bioavailability. Approaches to enhance bioavailability are widely cited in the literature. An attempt has been made to review the bioavailability complications and clinical therapeutics of poorly water soluble drug: cinnarizine. The interest of writing this paper is to summarize the pharmacokinetic limitations of drug with special focus on strategies to improvise bioavailability along with effectiveness of novel dosage forms to circumvent the obstacle. The paper provides insight to the approaches to overcome low and erratic bioavailability of cinnarizine by cyclodextrin complexes and novel dosage forms: self-nanoemulsifying systems and buoyant microparticulates. Nanoformulations need to systematically explored in future, for their new clinical role in prophylaxis of migraine attacks in children. Clinical reports have affirmed the role of cinnarizine in migraine prophylaxis. Research needs to be dedicated to develop dosage forms for efficacious bioavailability and drug directly to brain.

Biofiltration for removal of methyl isobutyl ketone (MIBK): experimental studies and kinetic modelling.

The present study deals with the biofiltration of methyl isobutyl ketone (MIBK), which is considered to be a highly toxic volatile organic compound. It is released from the paint and petrochemical industries and is one of the major contributors to air pollution. The biofiltration study was carried out on a lab scale for two months in the presence of acclimated mixed culture. The performance of the biofilter column was evaluated for different inlet loads of MIBK at air flow rates ranging from 0.18 to 0.3 m3 h(-1). The maximum removal efficiency of 93% was obtained after 60 days of biofilter operation for an inlet MIBK concentration of 0.45 g m(-3), and a microbial concentration of 2.36 x 10(8) CFU g(-1) of packing material was obtained. This led to a study of shock loadings for 20 days, by varying the inlet MIBK load and air flow rate after every five days, to observe the behaviour of the biofilter column in removing sudden loads of MIBK. The biokinetic constants r(max) and Ks were obtained using the Michaelis-Menten kinetics and were found to be 1.046 g m(-3) and 0.115 g m(-3) h(-1),respectively, with a coefficient of determination (R2) of 0.993. The obtained experimental results were validated with the Ottengraf and Van den Oever kinetic model. The critical inlet concentration, critical inlet load and biofilm thickness were also estimated using the results obtained from the model predictions.

Biodegradation kinetics of methyl iso-butyl ketone by acclimated mixed culture.

Methyl iso-butyl ketone (MIBK) is a widely used volatile organic compound (VOC) which is highly toxic in nature and has significant adverse effects on human beings. The present study deals with the removal of MIBK using biodegradation by an acclimated mixed culture developed from activated sludge. The biodegradation of MIBK is studied for an initial MIBK concentration ranging from 200-700 mg l(-1) in a batch mode of operation. The maximum specific growth rate achieved is 0.128 h(-1) at 600 mg l(-1)of initial MIBK concentration. The kinetic parameters are estimated using five growth kinetic models for biodegradation of organic compounds available in the literature. The experimental data found to fit well with the Luong model (R(2) = 0.904) as compared to Haldane model (R(2) = 0.702) and Edward model (R(2) = 0.786). The coefficient of determination (R(2)) obtained for the other two models, Monod and Powell models are 0.497 and 0.533, respectively. The biodegradation rate found to follow the three-half-order kinetics and the resulting kinetic parameters are reported.

Experimental studies and kinetic modeling for removal of methyl ethyl ketone using biofiltration.

The removal of toxic methyl ethyl ketone (MEK) is studied in a lab scale biofilter packed with mixture of coal and matured compost. The biofiltration operation is divided into 5 phases for a period of 60 days followed by shock loading conditions for three weeks. The maximum removal efficiency of 95% is achieved during phase II for an inlet concentration of 0.59 gm(-3), and 82-91% for the inlet concentration in the range of 0.45-1.23 gm(-3) of MEK during shock loads. The Michaelis-Menten kinetic constants obtained are 0.086 gm(-3)h(-1) and 0.577 gm(-3). The obtained experimental results are validated using Ottengraf-van den Oever model for zero-order diffusion-controlled region to understand the mechanism of biofiltration. The critical inlet concentration of MEK, critical inlet load of MEK and biofilm thickness are estimated using the results obtained from model predictions.